It’s almost time for the 4th Annual Maui Derm Caribbean Conference. The four-day meeting will take place from Jan. 7-10, 2026, at the Fairmont El San Juan Hotel in San Juan, Puerto Rico.
The 2026 meeting features fan-favorite presentations including updates on new drugs and devices and a comprehensive literature review, along with in-depth discussion on the full spectrum of dermatologic disease.
“I look forward to the new drugs and new therapies session, which keeps me abreast of recent drug approvals as well as new indications for current drugs. It also lets me know what’s coming in Phase 2 and 3, which is really exciting,” says Maui Derm Founder George Martin, MD.
Among other Maui Derm Caribbean 2026 highlights:
Peter A. Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine and a partner at Medical Dermatology Associates of Chicago in Chicago, IL, will moderate a panel on atopic dermatitis and itch. “I’m doing an update on the topical treatment landscape and just how incredible things are in the world of atopic dermatitis,” he says. “We will cover the new non-steroidal agents and talk about some of the new indications for lower ages (down to age 2), and how they can be leveraged both with and without systemic agents.”
Ted Rosen, MD, FAAD, a Professor of Dermatology at Baylor College of Medicine in Houston, TX, and the Medical Editor of The Dermatology Digest, will provide an update on the ever-changing world of infectious diseases. “Some infections continue to vex us, like COVID and MPXV, but re-emerging or increasingly resistant infections are about to become even more problematic,” he says.
Raj Chovatiya, MD, PhD, a Clinical Associate Professor of Dermatology, Rosalind Franklin University Chicago Medical School, North Chicago, IL, and Founder and Director of the Center for Medical Dermatology + Immunology Research in Chicago, IL, is taking on hidradenitis suppurativa (HS) and its emerging treatments. “HS is becoming the hot disease state when it comes to chronic inflammatory skin conditions. What’s happening with new and emerging therapies? Get ready for a rapid-fire update [on] topicals, biologics, and orals,” he says.
Victoria Werth, MD, a Professor of Dermatology at the University of Pennsylvania in Philadelphia and Advisor to Lupus Research Alliance’s clinical affiliate Lupus Therapeutics, will give an update on connective tissue disorders, including the latest in evolving therapies for lupus, dermatomyositis, and scleroderma.
Residents from the University of Puerto Rico’s Department of Dermatology will present on topics ranging from fascinating clinical cases to original research during the meeting.
Register for the meeting here.
Donβt miss out on exciting updates. Make sure to follow Maui Derm meetings on social media.
πFacebook
π¦Twitter / X
πLinkedIn
π§΅Threads
πΈInstagram